SEATTLE GENETICS INC's ticker is and the CUSIP is 812578952. A total of 3 filers reported holding SEATTLE GENETICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $7,900,000 | -1.8% | 92,500 | -22.6% | 0.00% | 0.0% |
| Q2 2019 | $8,042,000 | -43.0% | 119,500 | -37.9% | 0.00% | -33.3% |
| Q1 2019 | $14,099,000 | +198.0% | 192,500 | +130.5% | 0.00% | +200.0% |
| Q4 2018 | $4,731,000 | -45.2% | 83,500 | -25.4% | 0.00% | -50.0% |
| Q3 2018 | $8,637,000 | +333.6% | 112,000 | +273.3% | 0.00% | – |
| Q2 2018 | $1,992,000 | -56.7% | 30,000 | -65.1% | 0.00% | -100.0% |
| Q4 2017 | $4,601,000 | +70.5% | 86,000 | +72.0% | 0.00% | 0.0% |
| Q3 2017 | $2,698,000 | – | 50,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 772 | $2,870,000 | 0.11% |
| GROUP ONE TRADING, L.P. | 25,600 | $952,000 | 0.02% |
| Citadel Advisors | 55,900 | $2,078,000 | 0.00% |